fda tirzepatide announcement confirms shortage is still over, gives compounders a grace period FDA Grants Tirzepatide a New

And, if youre nervous, you might be doing it without even knowing

Importantly, these medications carry a boxed warning and contraindication for patients with personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)

GLP-1 RAs can help with weight loss by increasing feelings of fullness, reducing appetite, and slowing down gastric emptying, which can lead to reduced calorie intake

Both are peptides that activate the same two receptors

Long-term monitoring for pancreatitis or gallbladder issues is advised during treatment due to reported associations with GLP-1 receptor agonists